United Kingdom · Question · Written question
UIN 21994
NHS: Drugs
Introduced
16 April 2024
Last action
24 April 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
24 April 2024
Summary
To ask the Secretary of State for Health and Social Care, if she will have discussions with NHS England on the effectiveness of its Commercial Framework in tackling challenges presented by the appraisal and reimbursement system when applied to combination
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 April 2024
Written question
To ask the Secretary of State for Health and Social Care, if she will have discussions with NHS England on the effectiveness of its Commercial Framework in tackling challenges presented by the appraisal and reimbursement system when applied to combination
Source: Commons
24 April 2024
Answer
As part of the 2024 voluntary scheme for branded medicines pricing, access, and growth, NHS England has committed to undertake two consultations on its Commercial Framework for New Medicines. The first of these will be launched in summer 2024 and will ali...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-04-16/21994
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1701336
- uk · wq-1701336 · source updated 24 April 2024